DRKS00008790尚未招募1 期
Safety and clinical effectiveness of autologous mesenchymal stromal cell infusion as adjuncttreatment in patients with Idiopathic Pulmonary Fibrosis
The Republican Research and Practical Centre for Pulmonology and TB0 个研究点目标入组 40 人开始时间: 2015年7月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 21 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Patients 21 through 75 years of age with diagnose of IPF based on diagnostic criteria of An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management”. The duration of the disease should be more than three months, bilateral predominantly basilar inspiratory crackles should be present. In addition, the following functional abnormalities should be present: dyspnea, vital capacity of no more than 80 percent of the predicted value, single-breath carbon monoxide diffusing capacity (DLCO) less than 80 percent of the predicted value.
排除标准
- •Any one of the criteria below makes the patient non-eligible for enrolment into the study:
- •1.HIV positivity
- •2.Hepatitis B or C positivity
- •3. Tuberculosis
- •4.Autoimmune or systemic diseases
- •5.Pregnancy
- •6.liver, renal or other organ/system failure(s)
- •9.Younger than 21 years and older than 75 years
研究者
相似试验
招募中
Unknown
Clinical Study of Safety and Efficacy of Autologous Mesenchymal Stem Cells for Periodontal Tissue Regeneration TherapyPeriodontal DiseaseJPRN-jRCTb070230008Cho Yasushi22
已完成
不适用
Evaluation of safety and efficacy of autologous stentless mitral valve replacement: pilot studymitral valve stenosis, mitral valve stenosis and regurgitationJPRN-UMIN000026020Kyoto Prefectural University of Medicine
招募中
不适用
Efficacy of autologous adipose tissue-derived mesenchymal stem cell therapy in Duchenne muscular dystrophic patientsIRCT20150206020981N3Research Deputy of Islamic Azad University, Tehran Medical Branch10
进行中（未招募）
1 期
Development of tissue engineering therapy to treat patients with delayed consolidation after fracture of long bones.Closed or open Gustilo I ans II humerus, tibial or femur diaphyseal or metaphysodiaphyseal fracture.MedDRA version: 14.1 Level: PT Classification code 10017081 Term: Fracture delayed union System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-005441-13-DEINSERM30
进行中（未招募）
不适用
Development of a therapy to treat patients with delayed consolidation after fracture of long bonesClosed or open Gustilo I and II humerus, tibial or femur diaphyseal or metaphysodiaphyseal fractureMedDRA version: 14.1Level: PTClassification code 10017081Term: Fracture delayed unionSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-005441-13-ITINSERM - Institut National de la Sant? et de la Recherche m?dicale30